← Leaderboards
Kyle Andrew Tipton
Talis Biomedical Corporation
$1,109,538
Attributed
$1,109,538
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,109,538 · 1
By mechanism
R01$1,109,538 · 1
Top collaborators
No co-investigators on record.
Most similar at Talis Biomedical Corporation
Same institution · by research overlap
- Martin Goldberg$1,178,848
- Hedia Maamar$1,178,848
- Betty B Wu$2,219,076
Others in their field
Other Emerging Leaders on “Antibiotic Resistance”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$25,064,821
- Bruce Blough · Research Triangle Institute$19,880,022
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Terry Roemer · Prokaryotics, Inc.$13,917,276
Research focus
Antibiotic ResistanceAntibiotic-Resistant OrganismAntibioticsAntibiotic SusceptibilityAntibiotic TherapyAntimicrobialAntimicrobial ResistanceAntimicrobial SusceptibilityAreaBacterial Antibiotic ResistanceBacterial ResistanceBaseBioinformatics PipelineBloodBlood SpecimenCaliforniaCandida AlbicansCenters For Disease Control And Prevention (U.S.)ChemistryChicagoClinical DevelopmentCommunicable DiseasesConsumptionAmerican